Celgene (CELG), Acceleron Pharma (XLRN) Announce Submission of Luspatercept BLA to U.S. FDA
April 5, 2019 9:28 AM
Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced that Celgene has submitted a Biologics License Application ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
